Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer
Authors:
- Florian HuemerFHFlorian Huemer
- Thomas MelchardtTMThomas Melchardt
- Wolfgang TränkenschuhWTWolfgang Tränkenschuh
- Daniel NeureiterDaniel Neureiter
- Gerhard MoserGMGerhard Moser
- Teresa MagnesTMTeresa Magnes
- Lukas WeissLWLukas Weiss
- Alexander SchlattauASAlexander Schlattau
- Clemens HufnaglCHClemens Hufnagl
- Gerda RickenGRGerda Ricken
- Romana HöftbergerRHRomana Höftberger
- Richard GreilRGRichard Greil
Open Access
- 22 December 2015
- journal article
- case report
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-6
Abstract
Paraneoplastic syndromes are most frequently associated with small cell lung carcinoma, hematologic and gynecologic malignancies while reports in head and neck cancer are rare. We present the case of a 60-year old female patient who developed paraneoplastic cerebellar degeneration upon locoregional recurrence of a poorly differentiated spindle cell carcinoma of the nasal cavity and paranasal sinus. The neurological symptoms, especially ataxia, stabilized after resection of tumor recurrence and concomitant chemoradiotherapy whereas anti-Hu-antibodies remained positive. Despite the unfavorable prognosis of paraneoplastic neurological disorders associated with onconeural antibodies, the patient achieved long-standing stabilization of neurological symptoms. We report the first patient with anti-Hu antibodies and paraneoplastic cerebellar degeneration associated with a spindle cell carcinoma of the head and neck. We recommend that evaluation of neurological symptoms in patients with this tumor entity should also include paraneoplastic syndromes as differential diagnoses and suggest early extensive screening for onconeural antibodies.Keywords
This publication has 17 references indexed in Scilit:
- Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinomaJournal of Neuro-Oncology, 2009
- Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literatureEuropean Archives of Oto-Rhino-Laryngology, 2005
- Recommended diagnostic criteria for paraneoplastic neurological syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Paraneoplastic peripheral neuropathy associated with anti‐Hu antibodiesBrain, 2002
- Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisoloneJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Paraneoplastic syndromes in patients with head and neck cancerAmerican Journal of Otolaryngology, 1994
- Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Spindle-Cell Carcinoma of the Upper Aerodigestive Tract MucosaAmerican Journal of Surgical Pathology, 1986